Cite

HARVARD Citation

    Holmgaard, R. et al. (2016). Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy. Oncoimmunology. p. . [Online]. 
  
Back to record